HB At The Counter
Welcome to HB At The Counter, a news center created by Haynes Boone’s FDA group as a go-to resource for retailers and consumer products companies looking for insights and perspectives on key trends, regulatory developments, and other noteworthy happenings in the world of FDA regulated consumer products, including food, dietary supplements, cosmetics, CBD, over-the-counter drugs, and medical devices.
HB At The Counter aims to ensure you remain up-to-speed with easy access to emerging laws about consumer products and their advertising, and to provide practical resources for fast-moving teams. We invite you to read our publications below, including Year in Review reports, client alerts, and relevant articles to provide valuable knowledge and actionable guidance to your teams, empowering them to navigate the FDA landscape with confidence.
Stay informed on the latest FDA updates, regulatory changes and industry insights by subscribing to receive timely communications straight to your inbox. Contact us to set up your subscription and never miss a critical development.
Wrap Up of 2025 State Legislative Proposals to Restrict Food Additives or Color Additives
January 16, 2026MoCRA Update: FDA Withdraws Proposed Talc Rule, Citing MAHA Priorities and Testing Complexities
December 03, 2025Laboratory Developed Tests Rule Vacated Ahead of FDA’s First Compliance Deadline
April 03, 2025Major Food Allergen Revamp: Coconuts Are Out; Quail Eggs and Goat Milk Are In (Among Others)
February 04, 2025Citing No Risk to Humans, FDA Revokes Authorization of Color Additive Red No. 3
January 16, 2025Insanitary Conditions and the Risk of Microbial Contamination in Tattoo Inks
October 31, 2024Correcting Online Misinformation About FDA-Approved or Cleared Medical Products
October 18, 2024Public Meeting on FDA’s Proposed Process for Post-Market Assessment of Chemicals in Food
October 10, 2024FDA Obtains Approval for Massive Reorganization: What It Means for the Food Industry
June 04, 2024FDA Elaborates on its Hopes for Collaborating with Congress on a CBD Harm Reduction Approach
May 30, 2023